ACS-verified level 1 trauma centers and the effect of COVID-19 on research activities
| All n=40 | Academic n=34 (85%) | Non-academic n=6 (15%) | Total responses | |
| Facility characteristics | ||||
| Type of facility | 40 | |||
| Academic | 34 (85%) | – | – | |
| Non-academic | 6 (15%) | – | – | |
| Profit status | 39 | |||
| Non-profit | 32 (82%) | 29 (88%) | 3 (50%) | |
| For profit | 2 (5%) | 0 (0%) | 2 (33%) | |
| Government | 5 (13%) | 4 (12%) | 1 (17%) | |
| Part of a hospital system | 34 (85%) | 28 (82%) | 6 (100%) | 40 |
| Total licensed beds (median (IQR), range) | 509 (400–700), 249–1000 | 545 (400–710), 249–1000 | 440 (330–600), 250–800 | 38 |
| Approximate adult trauma admissions in the past 12 months (median (IQR), range) | 2300 (1500–3000), 1200–4800 | 2190 (1450–3100), 1200–4800 | 2450 (1500–3000), 1500–3100 | 38 |
| Years of ACS level 1 verification (median (IQR), range) | 20 (7–28), 1–36 | 20 (7–28), 1–36 | 14 (4–28), 3–30 | 40 |
| Effects of the COVID-19 pandemic | ||||
| Trauma service admissions reduced during COVID-19 | 14 (52%) | 11 (52%) | 3 (50%) | 27 |
| Admission reductions to levels below those required for level 1 verification | 2 (7%) | 2 (10%) | 0 (0%) | 27 |
| Scheduled for review during March to December 2020 | 14 (52%) | 12 (57%) | 2 (33%) | 27 |
| Resource diversion from research during COVID-19 | 12 (44%) | 9 (43%) | 3 (50%) | 27 |
| Consenting studies postponed during COVID-19 | 10 (37%) | 7 (33%) | 3 (50%) | 27 |
| Competing priorities during COVID-19 have made it difficult to fulfill level 1 requirements | 10 (40%) | 8 (42%) | 2 (33%) | 25 |
ACS, American College of Surgeons.